Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of California, Los Angeles, California; Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cedars Sinai Medical Center, Los Angeles, California.
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of California, Los Angeles, California; Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cedars Sinai Medical Center, Los Angeles, California.
Fertil Steril. 2015 Mar;103(3):694-8. doi: 10.1016/j.fertnstert.2014.12.090. Epub 2014 Dec 31.
To evaluate the relationship between blastomere number and aneuploidy.
Historical cohort study.
In vitro fertilization clinic.
PATIENT(S): Two hundred fifty-nine patients undergoing in vitro fertilization (IVF) in combination with comprehensive chromosomal screening of embryos.
INTERVENTION(S): A total of 1,915 embryos were biopsied on day 3 and underwent comprehensive chromosomal screening with microarray-based comparative genomic hybridization.
MAIN OUTCOME MEASURE(S): Relationship between day 3 blastomere number, aneuploidy rate, and progression to the blastocyst stage.
RESULT(S): A number of day 3 blastomeres >9 was associated with significantly increased aneuploidy rates. Rapidly developing embryos were significantly more likely to blastulate regardless of their chromosomal status. Number of embryos per patient greater than 13 was independently associated with lower aneuploidy rates after controlling for maternal age. This trend was not significant with the use of a more clinically relevant threshold of greater than six embryos per patient.
CONCLUSION(S): Embryos with 6-9 cells at the cleavage stage should be considered for transfer over embryos with >9 cells. Day 3 blastomere number may be used in conjunction with extended culture to improve selection of euploid embryos, especially when supernumerary embryos are available. Further studies are needed to show if these selection criteria improve clinical outcomes.
评估卵裂球数量与非整倍体之间的关系。
历史队列研究。
体外受精诊所。
259 名接受体外受精(IVF)联合胚胎综合染色体筛查的患者。
共有 1915 个胚胎在第 3 天进行活检,并进行了基于微阵列的比较基因组杂交的综合染色体筛查。
第 3 天卵裂球数、非整倍体率与囊胚形成阶段的关系。
第 3 天卵裂球数>9 与非整倍体率显著增加相关。快速发育的胚胎无论其染色体状态如何,囊胚形成的可能性显著增加。在控制母体年龄后,每位患者的胚胎数量大于 13 与非整倍体率降低独立相关。使用更具临床意义的每位患者大于 6 个胚胎的阈值,这种趋势并不显著。
卵裂期具有 6-9 个细胞的胚胎应优先于具有>9 个细胞的胚胎进行移植。第 3 天的卵裂球数可以与延长培养相结合,以改善整倍体胚胎的选择,特别是当有多余胚胎时。需要进一步的研究来表明这些选择标准是否可以改善临床结局。